BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20962896)

  • 1. Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis.
    Rechka A; Neagoe PE; Gratton JP; Sirois MG
    Can J Physiol Pharmacol; 2010 Oct; 88(10):968-76. PubMed ID: 20962896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MSK1 in the signaling pathway leading to VEGF-mediated PAF synthesis in endothelial cells.
    Marchand C; Favier J; Sirois MG
    J Cell Biochem; 2006 Aug; 98(5):1095-105. PubMed ID: 16479592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.
    Barthomeuf C; Lamy S; Blanchette M; Boivin D; Gingras D; Béliveau R
    Free Radic Biol Med; 2006 Feb; 40(4):581-90. PubMed ID: 16458188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
    Brkovic A; Sirois MG
    J Cell Biochem; 2007 Feb; 100(3):727-37. PubMed ID: 17115409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways.
    Maliba R; Lapointe S; Neagoe PE; Brkovic A; Sirois MG
    Cell Signal; 2006 Nov; 18(11):1947-57. PubMed ID: 16617006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
    Bernatchez PN; Rollin S; Soker S; Sirois MG
    J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
    Takahashi T; Yamaguchi S; Chida K; Shibuya M
    EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
    Gingras D; Lamy S; Béliveau R
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
    Kou R; SenBanerjee S; Jain MK; Michel T
    Biochemistry; 2005 Nov; 44(45):15064-73. PubMed ID: 16274253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
    J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH; Claesson-Welsh L
    Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells.
    Blanes MG; Oubaha M; Rautureau Y; Gratton JP
    J Biol Chem; 2007 Apr; 282(14):10660-9. PubMed ID: 17303569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
    Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
    Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocortin V may function as a signaling protein for vascular endothelial growth factor receptor-2/Flk-1.
    Wen Y; Edelman JL; Kang T; Sachs G
    Biochem Biophys Res Commun; 1999 May; 258(3):713-21. PubMed ID: 10329451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways.
    Bernatchez PN; Allen BG; Gélinas DS; Guillemette G; Sirois MG
    Br J Pharmacol; 2001 Nov; 134(6):1253-62. PubMed ID: 11704645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer.
    Neagoe PE; Lemieux C; Sirois MG
    J Biol Chem; 2005 Mar; 280(11):9904-12. PubMed ID: 15637071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
    List AF; Glinsmann-Gibson B; Stadheim C; Meuillet EJ; Bellamy W; Powis G
    Exp Hematol; 2004 Jun; 32(6):526-35. PubMed ID: 15183893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells.
    Chandra A; Angle N
    Surgery; 2005 Oct; 138(4):780-7. PubMed ID: 16269309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.